High-Risk Diffuse Large B-Cell Lymphoma
High-risk diffuse large B-cell lymphoma (DLBCL) is an aggressive form of lymphoma characterized by rapidly growing tumors in the lymphatic system, often requiring immediate treatment.
CD30-Positive Lymphoma: Brentuximab Imaging Study
We are investigating how a drug called Brentuximab distributes in the body of patients with CD30-positive lymphoma. This study may help improve future treatments for this type of cancer.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Lymphoma
Lymphoma is a type of cancer that originates in the lymphatic system, which is part of the body's immune system, and can cause symptoms like swollen lymph nodes and fatigue.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Medisch Centrum Groningen
Hematology
Groningen, Netherlands
Sponsor: Universitair Medisch Centrum Groningen
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.